Bengaluru based health startup SigTuple’s two co-founders, Rohit Kumar Pandey and Apurv Anand, have resigned from the company. Pandey and Anand along with Tathagato Rai Dastigar had founded SigTuple in 2015. Mr. Pandey has confirmed the news about his resignation to Techpluto.
“Yes, the news about my resignation is correct. I am in the transition phase after spending close to 5 years on this journey and I don’t have any specific plans for the future at this point in time,” Pandey said to Techpluto.
Pandey was the CEO while Anand served as the COO and CTO of the company. Following the sudden resignation of the two co-founders, Tathagato has once again taken over the role of CEO. This is second time that Tathagato has become CEO of the company. He was the CEO during first two years of company’s operations but handed over the position to Pandey in 2016.
Tathagato expressed his sense of disbelief while announcing the news of the resignation of both co-founders in his LinkedIn post.
“With a heavy heart, I have to share that Rohit and Apruv are in such a situation now, and have no choice but to relinquish their roles at SigTuple and move on. This was shock for everyone, most of all me. But given the considered reasons behind it, we couldn’t help but accept their decision,” Tathagato said in his LinkedIn post.
He further added that SigTuple is finding it increasingly difficult to raise funds and possibility of the same is very minimal in short to medium term. Therefore for the purpose of long term sustainability the company will have to tighten its expenditure.
As part of the cost-cutting, the company has reportedly closed multiple centers across the country. Tathagato clarified in his post that in order to give new direction to the company, it will branch into new avenues like microbiology.
SigTuple was founded with the aim to leverage the power of artificial intelligence to efficiently digitalize pathological tests. Its flagship product is called Manthan. The company claims that Manthan has helped in achieving smart screening solution in critical areas like blood smears, urine microscopy, semen, fundus & OCT scans and chest x-ray.
According to Crunchbase, till date the company has raised 40.8 Mn through five funding rounds. Its lasting funding of $16 Mn came in April, 2019. The company boasts marquee investors like Binny Bansal, Accel Partners and Chiratae Ventures.